File: '\\swfile\EmailIn\20240418 184929 Attachment MUSL - NR re_ Bridge Loan (April 2024).docx'

PROMINO NUTRITIONAL SCIENCES ANNOUNCES

$1,000,000 BRIDGE LOAN

BURLINGTON, ON, April 18, 2024 /CNW/ - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") is pleased to announce it has entered into an agreement (the "Loan Agreement") with a private British Columbia company (the "Lender") pursuant to which the Lender will make an unsecured bridge loan of up to $1,000,000 to the Company (the "Bridge Loan"). The Bridge Loan matures 12 months from the effective date of the Loan Agreement. Advances made under the Bridge Loan will accrue simple interest at a rate of 12% per annum starting from the date of such advance, payable semi-annually in arrears. The proceeds from the Bridge Loan will be used for general corporate and working capital purposes and repayment of indebtedness. Subject to approval of the Canadian Securities Exchange, if applicable, the Lender will have the option at any time after maturity to convert all or any part of the outstanding Bridge Loan into common shares of the Company at a price of $0.17 per share.

About Promino

Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate(TM), is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino(TM), an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.

To learn more about Promino, visit http://www.drinkpromino.com

More information about Rejuvenate(TM) can be found https://www.rejuvenatemuscle.com

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding: the Bridge Loan, including the timing of any advances made thereunder and the receipt of all regulatory approvals for the Bridge Loan and any conversion thereof into common shares of the Company; and the Company's business prospects, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, the Company will receive all regulatory approvals necessary for the Bridge Loan in a timely fashion, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Promino Nutritional Sciences Inc.

For further information:

Vito Sanzone, Chief Executive Officer, ir@elementnutrition.com, 289-348-1970 ext. 222;

Marc Charbin, Investor Relations, ir@elementnutrition.com, 416-467-5229